BridgeBio Pharma, Inc. (BBIO)
67.38
-0.71
(-1.04%)
USD |
NASDAQ |
May 07, 16:00
68.55
+1.17
(+1.74%)
After-Hours: 20:00
BridgeBio Pharma Research and Development Expense (Annual) : 451.95M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.25B |
| Mirum Pharmaceuticals, Inc. | 185.83M |
| Insmed, Inc. | 771.09M |
| Eli Lilly & Co. | 13.34B |
| Alnylam Pharmaceuticals, Inc. | 1.320B |